HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SIBN

SI-BONE, Inc. (NASDAQ)

Healthcare — Medical Devices

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

None 8 analysts
$16.68
$-0.36 (-2.11%)
Target: $24.13 (44.6%)
Sign in to add SIBN to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$749.95M
P/E Ratio (TTM)-
Forward P/E-47.92
EPS (TTM)$-0.39
Dividend Yield-
Profit Margin-8.10%
Revenue Growth11.20%
ROE-9.64%
Debt/Equity24.00
Recommendation None
Analyst Target$24.13
Analysts8
Indexes NASDAQ

Technical Indicators

RSI (14)68.3
Beta0.70
SMA 20-
SMA 40-
52-Week High$21.89
52-Week Low$11.48
50-Day Avg$14.50
200-Day Avg$15.72
Avg Volume664.4K
Volume278.2K

Performance Analysis

BULLISH

SIBN shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 50% of its 52-week range.
+ RSI at 68.3 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 11.2% year-over-year.
- Operating at a loss with -8.1% margin.
~ Wall Street consensus is "none" from 8 analysts.
+ Average analyst target of $24.12 implies 44.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:31 UTC

Back to Screener Export Report